Gapping down
In reaction to disappointing earnings/guidance: VIAB -1.8% (issued Q2 guidance).
M&A news: BUD -1.1% (reports suggesting China Mofcom is conducting an anti-trust probe on BUD and China Resources Snow Beer deal)
Other news: GLYC -13.2% (to offer and sell shares of its common stock in an underwritten public offering; size not disclosed), CMTL -12.6% (prices offering of 7,145,000 shares of its common stock at $14.00 per share), SEMG -4.5% (prices offering of 7.5 mln shares of its Class A common stock at $27.00 per share), INNL -4.5% (prices offering of 5,725,000 ordinary shares at $7.00 per share), MHG -2.4% (still checking), ERIC -1.7% (reports the company is being investigated over alleged corruption ), RARE -1.3% (Chief Medical Officer Sunil Agarwal resigns, effective Aug 18, to pursue other opportunities), NGG -1% (UK Times details comments from UK officials that co should be broken up)